@prefix this: <
http://www.tkuhn.ch/bel2nanopub/RAVc8-4bYcKUpfdzuqZmDMhK6TZhxzBxhjd3DYjmhx--Q
> .
@prefix sub: <
http://www.tkuhn.ch/bel2nanopub/RAVc8-4bYcKUpfdzuqZmDMhK6TZhxzBxhjd3DYjmhx--Q#
> .
@prefix beldoc: <
http://resource.belframework.org/belframework/20131211/knowledge/large_corpus.bel
> .
@prefix rdfs: <
http://www.w3.org/2000/01/rdf-schema#
> .
@prefix rdf: <
http://www.w3.org/1999/02/22-rdf-syntax-ns#
> .
@prefix xsd: <
http://www.w3.org/2001/XMLSchema#
> .
@prefix dct: <
http://purl.org/dc/terms/
> .
@prefix dce: <
http://purl.org/dc/elements/1.1/
> .
@prefix pav: <
http://purl.org/pav/
> .
@prefix np: <
http://www.nanopub.org/nschema#
> .
@prefix belv: <
http://www.selventa.com/vocabulary/
> .
@prefix prov: <
http://www.w3.org/ns/prov#
> .
@prefix schem: <
http://resource.belframework.org/belframework/20131211/namespace/selventa-legacy-chemicals/
> .
@prefix Protein: <
http://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI_36080
> .
@prefix hgnc: <
http://www.genenames.org/cgi-bin/gene_symbol_report?hgnc_id=
> .
@prefix geneProductOf: <
http://purl.obolibrary.org/obo/RO_0002204
> .
@prefix go: <
http://amigo.geneontology.org/amigo/term/GO:
> .
@prefix obo: <
http://purl.obolibrary.org/obo/
> .
@prefix occursIn: <
http://purl.obolibrary.org/obo/BFO_0000066
> .
@prefix species: <
http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=
> .
@prefix pubmed: <
http://www.ncbi.nlm.nih.gov/pubmed/
> .
@prefix orcid: <
http://orcid.org/
> .
sub:Head
{
this:
np:hasAssertion
sub:assertion
;
np:hasProvenance
sub:provenance
;
np:hasPublicationInfo
sub:pubinfo
;
a
np:Nanopublication
.
}
sub:assertion
{
sub:_1
geneProductOf:
hgnc:3309
;
a
Protein:
.
sub:_2
rdf:object
go:0008219
;
rdf:predicate
belv:increases
;
rdf:subject
sub:_1
;
a
rdf:Statement
.
sub:_3
occursIn:
obo:CLO_0001925
,
obo:CL_0000066
,
obo:UBERON_0003126
,
species:9606
;
rdf:object
sub:_2
;
rdf:predicate
belv:decreases
;
rdf:subject
schem:Tretinoin
;
a
rdf:Statement
.
sub:assertion
rdfs:label
"a(SCHEM:Tretinoin) -| (p(HGNC:ELANE) -> bp(GOBP:\"cell death\"))" , "p(HGNC:ELANE) -> bp(GOBP:\"cell death\")" .
}
sub:provenance
{
beldoc:
dce:description
"Approximately 61,000 statements." ;
dce:rights
"Copyright (c) 2011-2012, Selventa. All rights reserved." ;
dce:title
"BEL Framework Large Corpus Document" ;
pav:authoredBy
sub:_5
;
pav:version
"20131211" .
sub:_4
prov:value
"Treatment with retinoic acid itself (from 1010 to 106 M) did not alter the viability of BEAS-2B cells (Figure 2A), A549 cells (Figure 2B), or primary cultures of HTE cells (Figure 2C) for 24 h. However, retinoic acid inhibited decreases in cell viability induced by elastase in BEAS-2B cells (0.06 U/ml of elastase) (Figure 2D), A549 cells (0.3 U/ml of elastase) (Figure 2E), and HTE cells (3 U/ml of elastase) (Figure 2F)." ;
prov:wasQuotedFrom
pubmed:12594055
.
sub:_5
rdfs:label
"Selventa" .
sub:assertion
prov:hadPrimarySource
pubmed:12594055
;
prov:wasDerivedFrom
beldoc:
,
sub:_4
.
}
sub:pubinfo
{
this:
dct:created
"2014-07-03T14:31:59.105+02:00"^^
xsd:dateTime
;
pav:createdBy
orcid:0000-0001-6818-334X
,
orcid:0000-0002-1267-0234
.
}